| CSL Behring AG - Berirab 2 ml, Injektionslösung |
| 00687 | | 01 | | Berirab 2 ml | | Injektionslösung | | J06BB05 | | Tollwut-Immunglobulin | | 05.05.2004 | | |
|
| Composition |
| proteinum humanum 200-340 mg corresp. immunoglobulina min. 95 % corresp. immunoglobulinum humanum anti-rabies min. 300 U.I., immunoglobulinum humanum A max. 6.0 mg, glycinum, natrii chloridum, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 2 ml, natrium 3.144 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | | Agents auxilliaires | Concentr. |
|---|
| Glycine | | | Immunoglobulinum Humanum A | 6 mg | | Sodium Chlorure | | | Sodium Hydroxide | | | Proteinum Human | 200-340 mg |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | seringue(s) à 2 ml | | | B | | Non |
|
